PHUONG TRAN: Open Payments
NPI 1710197678 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,768 in 122 payments from 30 companies in 2025. Trend: 2023 $2,396 · 2024 $3,026 · 2025 $2,768
Food & beverage: $2,768
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $280 |
| PFIZER INC. | 11 | $240 |
| Cleerly, Inc. | 3 | $239 |
| Novo Nordisk Inc | 15 | $215 |
| Amgen Inc. | 14 | $207 |
| AstraZeneca Pharmaceuticals LP | 2 | $176 |
| Otsuka America Pharmaceutical, Inc. | 9 | $160 |
| ViiV Healthcare Company | 6 | $151 |
| ABBVIE INC. | 10 | $151 |
| Lilly USA, LLC | 9 | $115 |
Products named: Cleerly Ischemia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, AIRSUPRA, REXULTI, ELIQUIS, APRETUDE, Wegovy, EVENITY.
Industry payments across TX — which companies pay providers there.
